|Articles|November 1, 2002

Pharmacy Times

  • Volume 0
  • 0

Promising News on Stem Cells

In the future, type 1 diabetes patients may be able to avoid the need for daily insulin shots through transplants of insulin-producing stem cells. ?We have done 38 islet cell transplant procedures since 1999,? said Dr. Jonathan Lakey of the University of Alberta in Edmonton. ?And 87% of those patients are free of insulin therapy a year after transplantation.? (The islets of Langerhans are the insulin-making parts of the pancreas.)

The news is especially exciting because there is an acute shortage of transplantable pancreases worldwide. Stem cell therapy also reduces or eliminates transplant rejections. More work is necessary, however, including satisfying the concerns of those who object to using stem cells on ethical grounds.

Articles in this issue

almost 23 years ago

Genetic Differences and Medicines

almost 23 years ago

A Hidden Clotting Problem?

almost 23 years ago

Aspirin Delays Premature Labor

almost 23 years ago

Hypertension and Dementia

almost 23 years ago

Sometimes You Feel Like a Nut

almost 23 years ago

Pumping Iron and Beating Diabetes

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME